Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice

Blood

Volumn 88, Issue 3, 1996, Pages 955-961

  Morita, Toshiro ^b   Ikeda, Kazuma ^a   Douzono, Miyuki ^b   Yamada, Muneo ^b   Kimura, Fumihiko ^b   Kawakami, Kimihiro ^b   Sasaki, Kazunori ^b   Motoyoshi, Kazuo ^b   Takahara, Jiro ^b   Irino, Shozo ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COLONY STIMULATING FACTOR 1; COMPLEMENTARY DNA; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CANCER SURVIVAL; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GENE EXPRESSION; LUNG CARCINOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNOLOGY; VACCINATION;

EID: 10144250285     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.955.bloodjournal883955     Document Type: Article

References (43)

1. Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E: Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells. J Exp Med 177:1127, 1993
2. Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P: Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397, 1990
3. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E: Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172:1217, 1990
4. Ley V, Langlade DP, Kourilsky P, Larsson SE: Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo. Eur J Immunol 21:851, 1991
5. Tepper RI, Pattengale PK, Leder P: Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503, 1989
6. Golumbek PT, Lazenby AJ, Levitsky HI, Faffee LM, Karasuyama H, Baker M, Pardoll DM: Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713, 1991
7. Porgador A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, Eisenbach L: Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res 52:3679, 1992
8. Hock H, Dorsch M, Diamantstein T, Blankenstein T: Interleukin 7 induces CD4+ T cell-dependent tumor rejection. J Exp Med 174:1291, 1991
9. Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E, Tanaiyama T, Sakata T: Exogenous expression of mouse Interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA 86:9456, 1989
10. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E: Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50:7820, 1990
11. Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L: Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. J Immunol 150:1458, 1993
12. Blankenstein T, Qin ZH, Uberla K, Muller W, Rosen H, Volk HD, Diamantstein T: Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med 173:1047, 1991
13. Koshita Y, Itoh Y, Fujii S, Neda H, Takahashi M, Watanabe N, Kohgo Y, Niitsu Y: Mechanisms of tumor regression of TNF gene-transduced Meth-A cells transplanted in mice. Ann N Y Acad Sci 716:334, 1994
14. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V. Hamada H, Pardoll D, Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539, 1993
15. Ramarathinam L, Castle M, Wu Y, Liu Y: T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J Exp Med 179:1205, 1994
16. Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellstrom I, Hellstrom KE: Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med 179:523, 1994
17. Tepper RI, Mule JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5:153, 1994
18. Clark SC, Kamen R: The human hematopoietic colony-stimulating factors. Science 236:1229, 1987
19. Sieff CA: Hematopoietic growth factors. J Clin Invest 79:1549, 1987
20. Ralph P, Nakoinz I: Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1. Cell Immunol 105:270, 1987
21. Suzu S, Yokota H, Yamada M, Yanai N, Saito M, Kawashima T, Saito M, Takaku F, Motoyoshi K: Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res 49:5913, 1989
22. Munn DH, Cheung NK: Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays. J Exp Med 170:511, 1989
23. Sanda MG, Bolton E, Mule JJ, Rosenberg SA: In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells. J Immunother 12:132, 1992
24. Munn DH, Cheung NK: Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J Exp Med 172:231, 1990
25. Munn DH, Garnick MB, Cheung NK: Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood 75:2042, 1990
26. Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC: Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell Immunol 119:182, 1989
27. Lu L, Shen RN, Lin ZH, Aukerman SL, Ralph P, Broxmeyer HE: Anti-tumor effects of recombinant human macrophage colonystimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells. Int J Cancer 47:143, 1991
28. Moore RN, Oppenheim JJ, Farrar JJ, Carter CJ, Waheed A, Shadduck RK: Production of lymphocyte-activating factor (Interleukin 1 ) by macrophages activated with colony-stimulating factors. J Immunol 125:1302, 1980
29. Motoyoshi K, Yoshida K, Hatake K, Saito M, Miura Y, Yanai N, Yamada M, Kawashima T, Wong GG, Temple PA, Leary AC, Witek-Giannoti JS, Fujisawa M, Yuo A, Okabe T, Takaku F: Recombinant and native human urinary colony-stimulating factor directly augments granulocytic and granulocyte-macrophage colony-stimulating factor production of human peripheral blood monocytes. Exp Hematol 17:68, 1989
30. Warren MK, Ralph P: Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol 137:2281, 1986
31. Moore RN, Pitruzzello FJ, Robinson RM, Rouse BT: Interferon produced endogenously in response to CSF-1 augments the functional differentiation of progeny macrophages. J Leuk Biol 37:659, 1985
32. Katsura Y, Tsuru S, Noritake M, Shinomiya N, Kayashima S, Motoyoshi K, Rokutanda M: Effects of macrophage colony-stimulating factor on the activities of murine monocytes and peritoneal macrophages in vivo. Nat Immunol 11:167, 1992
33. Yuo A, Kitagawa S, Motoyoshi K, Azuma E, Saito M, Takaku F: Rapid priming of human monocytes by human hematopoietic growth factors: Granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists. Blood 79:1553, 1992
34. Bertram JS, Janik P: Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. Cancer Lett 11:63, 1980
35. Wong GG, Temple PA, Leary AC, Witek GJ, Yang YC, Ciarletta AB, Chung M, Murtha P, Kriz R, Kaufman RJ, Ferenz CR, Sibley BS, Turner KJ, Hewick RM, Clark SC, Yanai N, Yokota H, Yamada M, Saito M, Motoyoshi K, Takaku F: Human CSF-1: Molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science 235:1504, 1987
36. Akagi T, Nyunoya H, Shimotohno K: Murine retroviral vectors expressing the tax 1 gene of human T-cell leukemia virus type 1. Gene 106:255, 1991
37. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
38. Hanamura T, Motoyoshi K, Yoshida K, Saito M, Miura Y, Kawashima T, Nishida M, Takaku F: Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood 72:886, 1988
39. Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober W: Current Protocols in Immunology. New York, NY, Greene and Wiley-Interscience, 1991
40. Dorsch M, Hock H, Kunzendorf U, Diamantstein T, Blankenstein T: Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. Eur J Immunol 23:186, 1993
41. Young MR, Lozano Y, Coogan M, Wright MA, Young ME, Bagash JM: Stimulation of the metastatic properties of Lewis-lung-carcinoma cells by autologous granulocyte-macrophage colony-stimulating factor, Int J Cancer 50:628, 1992
42. Young MR, Young ME, Wright MA: Stimulation of immuno-suppressive bone marrow cells by colony-stimulating factors. Exp Hematol 18:806, 1990
43. Tepper RI, Coffman RL, Leder P: An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257:548, 1992